John David Finley is CEO, CFO, Director of PALISADE BIO, INC.. Currently has a direct ownership of 13,472 shares of PALI, which is worth approximately $61,162. The most recent transaction as insider was on May 28, 2024, when has been sold 2,033 shares (Common Stock, par value $0.01) at a price of $4.76 per share, resulting in proceeds of $9,677. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.5K
86.09% 3M change
77.68% 12M change
Total Value Held $61,162

John David Finley Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 28 2024
SELL
Payment of exercise price or tax liability
$9,677 $4.76 p/Share
2,033 Reduced 13.11%
13,472 Common Stock, par valu...
May 28 2024
BUY
Exercise of conversion of derivative security
-
7,068 Added 33.42%
14,079 Common Stock, par valu...
May 24 2024
BUY
Open market or private purchase
$4,810 $4.81 p/Share
1,000 Added 10.6%
8,437 Common Stock, par valu...
May 20 2024
BUY
Grant, award, or other acquisition
$3,310 $4.97 p/Share
666 Added 8.22%
7,437 Common Stock, par valu...
May 06 2024
SELL
Payment of exercise price or tax liability
$1,082 $8.46 p/Share
128 Reduced 1.86%
6,771 Common Stock, par valu...
May 06 2024
BUY
Exercise of conversion of derivative security
-
443 Added 6.09%
6,832 Common Stock, par valu...
Mar 11 2024
BUY
Exercise of conversion of derivative security
-
5,558 Added 5.43%
96,849 Common Stock, par valu...
Feb 06 2024
BUY
Exercise of conversion of derivative security
-
6,642 Added 6.78%
91,291 Common Stock, par valu...
Feb 06 2024
BUY
Open market or private purchase
$4,700 $0.47 p/Share
10,000 Added 10.57%
84,649 Common Stock, par valu...
Jan 31 2024
BUY
Open market or private purchase
$5,600 $0.56 p/Share
10,000 Added 11.81%
74,649 Common Stock, par valu...
Jan 03 2024
BUY
Exercise of conversion of derivative security
-
1,309 Added 1.98%
64,649 Common Stock, par valu...
Dec 11 2023
BUY
Exercise of conversion of derivative security
-
5,559 Added 8.07%
63,340 Common Stock, par valu...
Nov 20 2023
BUY
Grant, award, or other acquisition
$5,100 $0.51 p/Share
10,000 Added 14.75%
57,781 Common Stock, par valu...
Nov 06 2023
BUY
Exercise of conversion of derivative security
-
3,475 Added 6.78%
47,781 Common Stock, par valu...
Oct 04 2023
SELL
Payment of exercise price or tax liability
$218 $0.55 p/Share
397 Reduced 0.89%
44,306 Common Stock, par valu...
Oct 03 2023
BUY
Exercise of conversion of derivative security
-
1,309 Added 2.84%
44,703 Common Stock, par valu...
Sep 27 2023
BUY
Open market or private purchase
$8,100 $0.54 p/Share
15,000 Added 25.69%
43,394 Common Stock, par valu...
Sep 13 2023
BUY
Open market or private purchase
$9,900 $0.66 p/Share
15,000 Added 34.57%
28,394 Common Stock, par valu...
Sep 12 2023
SELL
Payment of exercise price or tax liability
$1,182 $0.66 p/Share
1,792 Reduced 11.8%
13,394 Common Stock, par valu...
Sep 11 2023
BUY
Exercise of conversion of derivative security
-
5,558 Added 26.79%
15,186 Common Stock, par valu...
Aug 11 2023
SELL
Payment of exercise price or tax liability
$728 $0.7 p/Share
1,040 Reduced 9.75%
9,628 Common Stock, par valu...
Aug 06 2023
BUY
Exercise of conversion of derivative security
-
3,475 Added 23.91%
11,057 Common Stock, par valu...
Jul 06 2023
SELL
Payment of exercise price or tax liability
$684 $1.76 p/Share
389 Reduced 5.13%
7,193 Common Stock, par valu...
Jul 03 2023
BUY
Exercise of conversion of derivative security
-
1,309 Added 14.72%
7,582 Common Stock, par valu...
Jun 13 2023
SELL
Payment of exercise price or tax liability
$1,617 $1.54 p/Share
1,050 Reduced 14.34%
6,273 Common Stock, par valu...
JDF

John David Finley

CEO, CFO, Director
Carlsbad,, CA

Track Institutional and Insider Activities on PALI

Follow PALISADE BIO, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PALI shares.

Notify only if

Insider Trading

Get notified when an Palisade Bio, Inc. insider buys or sells PALI shares.

Notify only if

News

Receive news related to PALISADE BIO, INC.

Track Activities on PALI